Insufficient scRNA-seq data for expression of IGFBPL1 at single-cell level.
Insufficient scRNA-seq data for expression of IGFBPL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 145.06 | 644 / 653 | 59% | 14.17 | 355 / 605 |
brain | 68% | 38.79 | 1794 / 2642 | 71% | 19.87 | 503 / 705 |
uterus | 45% | 16.34 | 76 / 170 | 57% | 15.47 | 263 / 459 |
blood vessel | 98% | 171.13 | 1306 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 15% | 6.36 | 39 / 258 | 70% | 37.34 | 161 / 230 |
lung | 25% | 5.77 | 144 / 578 | 55% | 9.75 | 641 / 1155 |
stomach | 44% | 12.39 | 159 / 359 | 31% | 8.54 | 88 / 286 |
bladder | 48% | 26.29 | 10 / 21 | 21% | 4.92 | 105 / 504 |
tonsil | 0% | 0 | 0 / 0 | 56% | 8.35 | 25 / 45 |
esophagus | 26% | 6.76 | 373 / 1445 | 27% | 3.37 | 50 / 183 |
eye | 0% | 0 | 0 / 0 | 48% | 4.94 | 38 / 80 |
ovary | 6% | 1.62 | 10 / 180 | 36% | 4.65 | 153 / 430 |
intestine | 19% | 4.43 | 188 / 966 | 20% | 2.61 | 106 / 527 |
pancreas | 9% | 1.73 | 29 / 328 | 24% | 2.57 | 43 / 178 |
breast | 4% | 0.84 | 18 / 459 | 29% | 2.93 | 320 / 1118 |
heart | 30% | 23.90 | 258 / 861 | 0% | 0 | 0 / 0 |
prostate | 22% | 7.19 | 55 / 245 | 6% | 0.42 | 31 / 502 |
liver | 1% | 0.24 | 3 / 226 | 25% | 4.53 | 102 / 406 |
adipose | 14% | 3.91 | 173 / 1204 | 0% | 0 | 0 / 0 |
skin | 1% | 0.27 | 24 / 1809 | 11% | 1.26 | 50 / 472 |
kidney | 6% | 1.16 | 5 / 89 | 3% | 0.32 | 28 / 901 |
peripheral blood | 3% | 1.18 | 27 / 929 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.16 | 8 / 803 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.10 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071228 | Biological process | cellular response to tumor cell |
GO_0009966 | Biological process | regulation of signal transduction |
GO_0001558 | Biological process | regulation of cell growth |
GO_0005615 | Cellular component | extracellular space |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005520 | Molecular function | insulin-like growth factor binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | IGFBPL1 |
Protein name | Insulin-like growth factor-binding protein-like 1 (IGFBP-related protein 10) (Insulin-like growth factor-binding-related protein 4) (IGFBP-rP4) Insulin-like growth factor binding protein-like 1 |
Synonyms | IGFBPRP4 |
Description | FUNCTION: IGF-binding proteins prolong the half-life of IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs in cell culture. They alter the interaction of IGFs with their cell surface receptors (By similarity). May be a putative tumor suppressor protein. . |
Accessions | Q8WX77 A0A286RQC1 ENST00000377694.2 |